(Q43667872)
Statements
1 reference
A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway (English)
1 reference
François C
1 reference
Toumi M
1 reference
Aakhus AM
1 reference
Hansen K
1 reference
1 January 2003
1 reference
1 reference
4
1 reference
1
1 reference
12-19
1 reference
Identifiers
1 reference
1 reference